Work

Use of 5-α-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline

Year: 2020

Type: article

Abstract: To develop an evidence-based guideline on the use of 5-α-reductase inhibitors (5-ARIs) for prostate cancer chemoprevention.

Source: Carolina Digital Repository (University of North Carolina at Chapel Hill)

DOI: 10.17615/s65e-8p24

Authors: Somerfield, Mark R., Harris, Russell P., Wilt, Timothy J., Blot, William J., Albertsen, Peter C., Costantino, Joseph P., Schellhammer, Paul, Godley, Paul A., Wittes, Janet, Zon, Robin, Justman, Stewart, Epstein, Jonathan I., Hagerty, Karen L., Ballentine Carter, H., Kramer, Barnett S.

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: GlaxoSmithKline, American Society of Clinical Oncology

OpenAlex ID: W4299538927

FWCI:

Cites:

Cited by:

Related to: 10